Profil
Cenk Sumen worked as a Director at Thermo Fisher Scientific, Inc. and as a Senior Manager-Business Development at Minaris Regenerative Medicine LLC from 2014 to 2018.
He was also the Chief Scientific Officer at MaxCyte, Inc. from 2022 to 2024.
Currently, he is the Chief Technology Officer at Stemson Therapeutics, LLC.
Dr. Sumen received his undergraduate and doctorate degrees from Stanford University.
Anciens postes connus de Cenk Sumen
| Sociétés | Poste | Fin |
|---|---|---|
| MAXCYTE, INC. | Directeur Technique/Scientifique/R&D | 23/01/2024 |
| THERMO FISHER SCIENTIFIC, INC. | Directeur/Membre du Conseil | 01/04/2018 |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Provides cell therapy services | Corporate Officer/Principal | 01/04/2018 |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to grow new hair follicles | Directeur Technique/Scientifique/R&D | - |
Formation de Cenk Sumen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Provides cell therapy services | Health Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to grow new hair follicles | Commercial Services |
















